Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC O-43:2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002413 AN003934 IFN-inducible phospholipid levels govern endosomal antiviral immunity Cultured cells Human University of Colorado Denver LC-MS
  logo